Karch, A.* ; Vogelmeier, C.* ; Welte, T.* ; Bals, R.* ; Kauczor, H.U.* ; Biederer, J.* ; Heinrich, J. ; Schulz, H. ; Gläser, S.* ; Holle, R. ; Watz, H.* ; Korn, S.* ; Adaskina, N.* ; Biertz, F.* ; Vogel, C.* ; Vestbo, J.* ; Wouters, E.F.M.* ; Rabe, K.F.* ; Söhler, S.* ; Koch, A.* ; Jörres, R.A.*
The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.
Respir. Med. 114, 27-37 (2016)
Background The German COPD cohort study COSYCONET ("COPD and SYstemic consequences-COmorbidities NETwork") investigates the interaction of lung disease, comorbidities and systemic inflammation. Recruitment took place from 2010 to 2013 in 31 study centers. In addition to the baseline visit, follow-up visits are scheduled at 6, 18, 36 and 54 months after baseline. The study also comprises a biobank, image bank, and includes health economic data. Here we describe the study design of COSYCONET and present baseline data of our COPD cohort. Methods Inclusion criteria were broad in order to cover a wide range of patterns of the disease. In each visit, patients undergo a large panel of assessments including e.g. clinical history, spirometry, body plethysmography, diffusing capacity, blood samples, 6-min walk-distance, electrocardiogram and echocardiography. Chest CTs are collected if available and CTs and MRIs are performed in a subcohort. Data are entered into eCRFs and subjected to several stages of quality control. Results Overall, 2741 subjects with a clinical diagnosis of COPD were included (59% male; mean age 65 ± 8.6 years (range 40-90)). Of these, 8/35/32/9% presented with GOLD stages I-IV; 16% were uncategorized, including the former GOLD-0 category. 24% were active smokers, 68% ex-smokers and 8% never-smokers. Data completeness was 96% for the baseline items. Conclusion The German COPD cohort comprises patients with advanced and less advanced COPD. This is particularly useful for studying the time course of COPD in relation to comorbidities. Baseline data indicate that COSYCONET offers the opportunity to investigate our research questions in a large-scale, high-quality dataset.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cohort ; Comorbidity ; Copd ; Study Design ; Systemic Inflammation; Obstructive Pulmonary-disease; Air-flow Limitation; Quality-of-life; Systemic Inflammation; General-population; Lung-function; Gold Classification; Reference Values; Body-mass; Comorbidities
Keywords plus
Sprache
Veröffentlichungsjahr
2016
Prepublished im Jahr
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0954-6111
e-ISSN
1532-3064
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 114,
Heft: ,
Seiten: 27-37
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30503 - Chronic Diseases of the Lung and Allergies
30202 - Environmental Health
80000 - German Center for Lung Research
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-503900-003
G-503900-001
G-505300-002
G-501800-391
Förderungen
Copyright
Erfassungsdatum
2016-04-14